THIS IS NOT A SOLICITATION ANNOUNCEMENT. This is a Sources Sought Notice and is issued solely for information and planning purposes - it does not constitute a Request for Quote (RFQ) or a promise to issue an RFQ in the future. Solicitations are not available at this time and requests for a solicitation will not receive a response. This notice does not constitute a commitment by the United States Government to contract for any supply or service whatsoever. All information submitted in response to this announcement is voluntary; the United States Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the United States Government. Not responding to this Sources Sought Notice does not preclude participation in any future RFQ, should one be issued. If a solicitation is released, it will be synopsized on FedBizOpps (www.fbo.gov), the Governmentwide point of entry (GPE). It is the responsibility of the potential offerors to monitor this site for additional information pertaining to this requirement.

The Government will use responses to this notice in formulating its acquisition strategy. If the Government does not receive sufficient information in response to this notice to verify the potential for competition exists, it is possible that a sole-source contract, supported by a Justification and Approval document, will be issued to support the Government's requirement.

The Regional Health Contracting Office - Central (RHCO-C) is issuing this Sources Sought Notice to find potential sources that can provide reagents for Methicillin Resistant Staphylococcus Aureus (MRSA) testing that are compatible with Cepheid GeneXpert XVI analyzers. These Government-owned analyzers are located within the Department of Pathology and Area Laboratory Services (DPALS) Microbiology Labs, San Antonio Military Medical Center (SAMMC), Joint Base San Antonio - Fort Sam Houston, TX 78234.

RHCO-C is seeking the following information (please answer each paragraph below):

Vendors shall provide the following information:

1. Company name, DUNS number, CAGE code, and point of contact information (including phone number and email address).

2. Size of business with regards to North America Industry Classification System (NAICS) code 325413 "In-Vitro Diagnostics Substance Manufacturing," to include any applicable socio-economic categories (e.g., HUBZone, 8(a), Small Disadvantaged, Service Disabled Veteran Owned, Veteran Owned, Women Owned, and Other-than-Small).

3. Capability Statement (limited to three pages), describing how they would successfully deliver reagents and any necessary consumable items, in accordance with all applicable U.S. laws, regulations, policies, and procedures and the attached Statement of Objectives, to include compatibility with the Cepheid GeneXpert XVI analyzers (ECN 164893 & 108531), which are owned by the Government.

The response due date for this sources sought is 12PM CST, August 12, 2019. All questions and comments regarding this announcement shall be addressed in writing via email to the below POCs:

Patricia Pfeninger
Contract Specialist
Regional Health Contracting Office - Central
[email protected]

Michelle Bartkowski
Contracting Officer
Regional Health Contracting Office - Central
[email protected]

 

Bid Protests Not Available